Drug Profile
Monoclonal antibody ZME-018-gelonin conjugate
Latest Information Update: 14 Jul 1998
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Drug conjugates; Immunotoxins; Monoclonal antibodies
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 14 Jul 1998 Profile reviewed
- 14 Jul 1998 No-Development-Reported for Cancer in USA (Unknown route)
- 15 Sep 1995 Preclinical development for Cancer in USA (Unknown route)